Exemption number e2019001.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of pericardial effusion and hypotension, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.Based on the information reviewed, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
This is filed to report the pericardial effusion.It was reported this was a mitraclip procedure to treat grade 4+ mixed mitral regurgitation (mr).When crossing the septum into the left atrium, the steerable guide catheter (sgc) was inadvertently advanced towards the left upper pulmonary vein.The procedure was continued and the mitraclip delivery system was advanced, the patient became bradycardic and hypotensive, requiring medication.A pericardial effusion was noted and pericardiocentesis was performed.The clip was deployed after pericardiocentesis and the symptoms resolved.The procedure was aborted, another clip may be implanted at a future date.Mr was reduced to 3-4.It is suspected the dilator/sgc caused the effusion when crossing the septum into the left atrium.No additional information was provided.
|